Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT07270380
Clinical Trial
Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin.
Study acronym:
ADOPT GG
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this trial is to determine if genex with gentamicin (genex G) an antibiotic loaded bone void filler, works to treat and is a safe option as part of the surgical treatment of osteomyelitis in the extremities.
Protocol Amendment History
2 changes
notable
Trial sites expanded: 1 -> 4 locations
2026-07-29
critical
Recruitment opened
2026-05-12
Trial Details
NCT Number
NCT07270380
Lead Sponsor
Biocomposites Ltd
Conditions
Osteomyelitis
Enrollment
139 participants
Start Date
2026-06
Primary Completion
2027-10
(estimated)
Study Completion
2028-10
(estimated)
Updated on ClinicalTrials.gov
2026-07-28